Vexev announced today that it raised $6 million in new funding to accelerate the progress of its robotic tomographic ultrasound platform. Existing investors Blackbird Ventures, Neotribe Ventures, Startmate and Horizon participated in the round. New investors TreeArc Investment Group, TEN13, Bioshore Ventures and Alumni Ventures all joined as well. The company plans to use funds to […]
About Sean Whooley
Solventum to separate Health Information Systems business
Solventum (NYSE:SOLV) today announced plans to separate its Health Information Systems business as part of its portfolio optimization strategy. The company — a spinoff itself from the one-time 3M Health Care business — intends to evaluate a range of separation pathways. Eagan, Minnesota-–based Solventum said it aims to maximize shareholder value and position the company […]
LivaNova raises guidance on Q2 beats
LivaNova (Nasdaq:LIVN) today increased its full-year sales and earnings guidance on strong second-quarter financial results. The company now expects full-year revenue growth between 8% and 9%. It previously forecast between 7% and 8%. For adjusted earnings per share (EPS), the company now expects between $4.30 and $4.40, compared to a prior range of $4.20 to […]
BlueWind Medical earns FDA clearance for next-gen tibial neuromod system
BlueWind Medical announced today that it received FDA 510(k) clearance for Revi Extend, its next-generation implant. The next-generation implantable tibial neuromodulation (ITNM) system for urgency urinary incontinence (UUI) features an extended life of 15 years, reinforcing the durability of Revi for UUI. The system previously featured a 10-year lifetime. Revi is implanted near the ankle […]
Insulet slightly lowers 2026 sales growth outlook despite Q2 beats
Insulet (Nasdaq:PODD) slightly lowered its 2026 sales growth guidance despite second-quarter results that handily beat Wall Street estimates. The company previously projected total annual sales growth between 21% and 23%. However, it lowered that outlook by 1 percentage point at each end to 20%-22%. The company did increase its adjusted EPS guidance, though, expecting growth […]
Zimmer Biomet raises guidance on Q2 beats
Zimmer Biomet (NYSE:ZBH) today increased its 2026 outlook after posting Street-beating second-quarter results. The company increased its expected revenue growth from a range of 2.5%–4.5% to 3.9%–4.9%. It also increased its expectations for adjusted earnings per share (EPS), going from a range of $8.40–$8.55 to $8.47–$8.59. Shares of ZBH ticked up nearly 3% to $98.56 […]
Jury says Medtronic must pay $88M in Covidien hernia mesh suit
A federal jury in Massachusetts ruled that Medtronic (NYSE:MDT) must pay $88 million in damages related to its Covidien unit’s hernia mesh implants. Larry Patterson and his wife, Tammy Patterson, filed a lawsuit in 2022 alleging that Medtronic failed to provide a warning related to the potential dangers that come with the hernia mesh implant […]
Staar Surgical picks current COO, former J&J exec as new CEO
Staar Surgical (Nasdaq:STAA) announced today that it appointed Warren Foust as its new president and CEO. The appointment went into effect today, Aug. 4, 2026. Alongside Foust’s appointment, Lake Forest, California-based Staar named Deborah Andrews, its CFO, an EVP as well. Foust and Andrews became interim co-CEOs in February, following the resignation of CEO Stephen […]
Aqua Medical picks new CEO with RF ablation experience
Aqua Medical announced today that it named Robert “Bob” Haggerty as its new president and CEO, effective July 31, 2026. Haggerty succeeds Lloyd Mencinger, who intends to step down after nine years as CEO. He plans to support the transition through September before moving into retirement. Pleasanton, California-based Aqua Medical’s new CEO joins as the […]
Masimo names a new president
Masimo, a Danaher (NYSE:DHR) company, announced that it appointed Tim Benner as its president, effective Aug. 3, 2026. Benner’s appointment comes at the same time as Danaher’s naming of Julie Sawyer Montgomery as its new president and CEO. Sawyer Montgomery oversaw Danaher’s $10 billion acquisition of Masimo and led the unit in its early days as […]
ReCor Medical promotes COO to corner office
Recor Medical announced today that it appointed Helen Reeve-Stoffer as its new president and CEO. Reeve-Stoffer, who most recently served as COO, succeeds Lara Barghout in the corner office at Recor, an Otsuka portfolio company. As CEO, she will continue to lead the company’s development and commercialization efforts for the Paradise ultrasound renal denervation (uRDN) […]
